Remeditex Ventures LLC Owns Stake in Venaxis Inc. (APPY)
Remeditex Ventures LLC recently stated that they own a 6.6% stake in Venaxis Inc. (NASDAQ:APPY) in a Schedule 13G disclosure that was filed with the Securities and Exchange Commission (SEC) on Monday, September 19th. The investor owns 295,210 shares of the stock valued at approximately $1,322,541. The reporting parties listed on the disclosure included Remeditex Ventures LLC, Malachite Trust and Lyda Hill. The disclosure is available through Edgar at this link.
Venaxis Inc. (NASDAQ:APPY) traded up 0.4487% during mid-day trading on Monday, hitting $4.5001. 101,355 shares of the company were exchanged. The company’s 50-day moving average is $3.44 and its 200 day moving average is $3.14. Venaxis Inc. has a 12-month low of $1.60 and a 12-month high of $6.65. The company’s market capitalization is $17.44 million.
Venaxis, Inc (Venaxis) is an in vitro diagnostic company that is focused on commercializing its blood-based test to serve as an adjunctive test in the diagnosis and treatment of acute appendicitis in children, adolescent and young adults. The Company’s test, the APPY1 Test, is a blood test panel for aiding in identifying patients in the emergency department that are at low risk for acute appendicitis.
Want to see what other hedge funds are holding APPY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Venaxis Inc. (NASDAQ:APPY).
Receive News & Ratings for Venaxis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venaxis Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.